
Dimension is a multistage, research-oriented venture capital firm partnering with companies across the frontiers of science and compute. Founded in 2022 by Zavain Dar, Adam Goulburn, and Nan Li, it invests at the intersection of life sciences and technology, including AI-driven drug discovery, computational biology, and software infrastructure for biopharma.
30% of their portfolio is in Biotech & Life Sciences. Deal activity increased 67% year-over-year (5 deals in the last 12 months). Average disclosed round size is $112.7M (across 19 rounds with reported amounts).
Portfolio
19
Fund Size
$500M
Top Stage
Series B
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
23 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| LLanyon AI | Unknown | $10.6M | Aug 2026 |
| Series B | $39.5M | Mar 2026 | |
| Series C | $45M | Jan 2026 | |
| Unknown | $787M | Jan 2026 | |
| Series B | $130M | Dec 2025 | |
| Series A | $17M | Sep 2025 | |
| Series A | — | Aug 2025 | |
| Seed | $12M | May 2025 | |
| Series B | $130M | May 2025 | |
| Series B | $115M | Jan 2025 | |
| Series D | $150M | Jan 2025 | |
| Seed | $12M | Jan 2025 | |
| KKimia Therapeutics | Series A | $55M | Dec 2023 |
| UUtaite Co Ltd | Unknown | — | Oct 2023 |
| Series C | $40M | Oct 2023 | |
| Series B | $40M | Oct 2023 | |
| Series B | $4.1M | Jun 2023 | |
| Series A | — | May 2023 | |
| Series A | $55M | Jan 2023 | |
| Series F | $233M | — | |
| Seed | $33M | — | |
| Series F | $233M | — | |
| Unknown | — | — |
Top Co-Investors
Octopus Ventures3 shared
Menlo Ventures2 shared
Yosemite2 shared
OpenAI Startup Fund2 shared
Neo2 shared
Thrive Capital2 shared
SV Angel2 shared
Kleiner Perkins2 shared
Founders Fund2 shared
A.P. Moller Holding2 shared
Isomer Capital2 shared
Possible Ventures2 shared
Hummingbird Ventures2 shared
Hadean Ventures2 shared
Horizons Ventures2 shared
The Column Group2 shared
Village Global2 shared
BoxOne Ventures2 shared
Caffeinated Capital2 shared
Last updated: 8 September 2026